Vassallo Jeffrey D, Hicks Sarah M, Daston George P, Lehman-McKeeman Lois D
Miami Valley Laboratories, The Procter and Gamble Company, 11810 East Miami River Road, Cincinnati, Ohio 45252, USA.
Toxicol Sci. 2004 Aug;80(2):249-57. doi: 10.1093/toxsci/kfh162. Epub 2004 May 12.
Hepatotoxicity of coumarin is attributed to metabolic activation to an epoxide intermediate, coumarin 3,4-epoxide (CE). However, whereas rats are most susceptible to coumarin-induced hepatotoxicity, formation of CE is greatest in mouse liver microsomes, a species showing little evidence of hepatotoxicity. Therefore, the present work was designed to test the hypothesis that detoxification of CE is a major determinant of coumarin hepatotoxicity. CE can either rearrange spontaneously to o-hydroxyphenylacetaldehyde (o-HPA) or be conjugated with gluatathione (GSH). o-HPA is hepatotoxic and is further detoxified by oxidation to o-hydroxyphenylacetic acid (o-HPAA). In vitro experiments were conducted using mouse liver microsomes to generate a constant amount of CE, and cytosols from F344 rats, B6C3F1 mice, and human liver were used to characterize CE detoxification. All metabolites were quantified by HPLC methods with UV detection. In rats and mice, GSH conjugation occurred non-enzymatically and through glutathione-S-transferases (GSTs), and the kinetics of GSH conjugation were similar in rats and mice. In rat liver cytosol, oxidation of o-HPA to o-HPAA was characterized with a high affinity K(m) of approximately 12 microM, and a V(max) of approximately 1.5 nmol/min/mg protein. In contrast, the K(m) and V(max) for o-HPA oxidation in mouse liver cytosol were approximately 1.7 microM and 5 nmol/min/mg protein, respectively, yielding a total intrinsic clearance through oxidation to o-HPAA that was 20 times higher in mouse than in rats. Human cytosols (two separate pools) detoxified CE through o-HPA oxidation with an apparent K(m) of 0.84 microM and a V(max) of 5.7 nmol/min/mg protein, for a net intrinsic clearance that was more than 50 times higher than the rat. All species also reduced o-HPA to o-hydroxyphenylethanol (o-HPE), but this was only a major reaction in rats. In the presence of a metabolic reaction replete with all necessary cofactors, GSH conjugation accounted for nearly half of all CE metabolites in rat and mouse, whereas the GSH conjugate represented only 10% of the metabolites in human cytosol. In mouse, o-HPAA represented the major ring-opened metabolite, accounting for the remaining 50% of metabolites, and in human cytosol, o-HPAA was the major metabolite, representing nearly 90% of all CE metabolites. In contrast, no o-HPAA was detected in rats, whereas o-HPE represented a major metabolite. Collectively, these in vitro data implicate o-HPA detoxification through oxidation to o-HPAA as the major determinant of species differences in coumarin-induced hepatotoxicity.
香豆素的肝毒性归因于其代谢活化生成环氧化中间产物香豆素3,4-环氧化物(CE)。然而,尽管大鼠对香豆素诱导的肝毒性最为敏感,但CE在小鼠肝微粒体中的生成量却是最大的,而小鼠几乎没有肝毒性的迹象。因此,本研究旨在验证以下假设:CE的解毒作用是香豆素肝毒性的主要决定因素。CE可自发重排为邻羟基苯乙醛(o-HPA),或与谷胱甘肽(GSH)结合。o-HPA具有肝毒性,并通过氧化进一步解毒为邻羟基苯乙酸(o-HPAA)。利用小鼠肝微粒体进行体外实验以生成恒定数量的CE,并使用F344大鼠、B6C3F1小鼠和人肝脏的胞质溶胶来表征CE的解毒作用。所有代谢产物均通过带有紫外检测的高效液相色谱法进行定量。在大鼠和小鼠中,GSH结合反应既可以非酶方式发生,也可以通过谷胱甘肽-S-转移酶(GSTs)发生,并且GSH结合反应的动力学在大鼠和小鼠中相似。在大鼠肝胞质溶胶中,o-HPA氧化为o-HPAA的特征为:高亲和力米氏常数(K(m))约为12微摩尔,最大反应速度(V(max))约为1.5纳摩尔/分钟/毫克蛋白。相比之下,小鼠肝胞质溶胶中o-HPA氧化的K(m)和V(max)分别约为1.7微摩尔和5纳摩尔/分钟/毫克蛋白,通过氧化生成o-HPAA的总内在清除率在小鼠中比在大鼠中高20倍。人胞质溶胶(两个独立样本)通过o-HPA氧化对CE进行解毒,表观K(m)为0.84微摩尔,V(max)为5.7纳摩尔/分钟/毫克蛋白,净内在清除率比大鼠高50倍以上。所有物种也都将o-HPA还原为邻羟基苯乙醇(o-HPE),但这仅在大鼠中是主要反应。在存在所有必需辅因子的代谢反应中,GSH结合反应在大鼠和小鼠中占所有CE代谢产物的近一半,而GSH结合物在人胞质溶胶中仅占代谢产物总量的10%。在小鼠中,o-HPAA是主要的开环代谢产物,占其余50%的代谢产物,而在人胞质溶胶中,o-HPAA是主要代谢产物,占所有CE代谢产物的近90%。相比之下,在大鼠中未检测到o-HPAA,而o-HPE是主要代谢产物。总体而言,这些体外数据表明,通过氧化生成o-HPAA对o-HPA进行解毒是香豆素诱导的肝毒性物种差异的主要决定因素。